ZCY Stock Chart & Stats
€2.84
-€0.04(-1.39%)
At close: 4:00 PM EDT
€2.84
-€0.04(-1.39%)
Day’s Range― - ―
52-Week Range€2.32 - €3.88
Previous CloseN/A
Volume0.00
Average Volume (3M)50.00
Market Cap
€27.13M
Enterprise Value€32.94
Total Cash (Recent Filing)€3.16M
Total Debt (Recent Filing)€8.96M
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Oct 09, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding8,062,650
10 Day Avg. Volume150
30 Day Avg. Volume50
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-1.73
Price to Sales (P/S)1.02
P/FCF Ratio6.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)€26.32M
Bulls Say, Bears Say
Bulls Say
Strong Gross MarginA gross margin near 77% indicates the core collection, processing, and storage services retain substantial contribution after direct costs. This provides operating leverage potential if revenue stabilizes and overhead is better controlled.
Positive Cash GenerationPositive operating and free cash flow provide an important funding source for ongoing operations and facility needs without relying heavily on external capital. The improvement versus the prior annual period is a durable financial strength, though revenue pressure must be monitored.
Low Absolute DebtLow absolute debt reduces near-term interest and refinancing exposure and may preserve operational flexibility compared with a highly leveraged structure. This benefit is partly constrained by the company’s negative equity position, but limited debt remains a relative strength.
Bears Say
Revenue ContractionA sharp revenue decline threatens both upfront enrollment revenue and the future base of recurring storage fees. Continued contraction could weaken customer acquisition economics, reduce operating leverage, and make the current cost structure harder to support.
Recurring UnprofitabilityNegative operating profit shows that the strong gross margin is not covering overhead and other costs. Earnings have also been volatile across recent years, limiting internally generated capital and increasing dependence on sustained cash-flow support.
Deeply Negative EquityDeeply negative equity signals a strained capital structure and reduces financial resilience if cash generation weakens. It can restrict access to financing, limit flexibility for investment, and leave less balance-sheet protection against further operating losses.
Cryo-Cell International News
ZCY FAQ
What was Cryo-Cell International Inc’s price range in the past 12 months?
Cryo-Cell International Inc lowest stock price was €2.32 and its highest was €3.88 in the past 12 months.
What is Cryo-Cell International Inc’s market cap?
Cryo-Cell International Inc’s market cap is €27.13M.
When is Cryo-Cell International Inc’s upcoming earnings report date?
Cryo-Cell International Inc’s upcoming earnings report date is Oct 09, 2026 which is in 50 days.
How were Cryo-Cell International Inc’s earnings last quarter?
Cryo-Cell International Inc released its earnings results on Jul 15, 2026. The company reported €0.061 earnings per share for the quarter, beating the consensus estimate of €0 by €0.061.
Is Cryo-Cell International Inc overvalued?
According to Wall Street analysts Cryo-Cell International Inc’s price is currently Overvalued.
Does Cryo-Cell International Inc pay dividends?
Cryo-Cell International Inc does not currently pay dividends.
What is Cryo-Cell International Inc’s EPS estimate?
Cryo-Cell International Inc’s EPS estimate is 0.03.
How many shares outstanding does Cryo-Cell International Inc have?
Cryo-Cell International Inc has 8,062,650 shares outstanding.
What happened to Cryo-Cell International Inc’s price movement after its last earnings report?
Cryo-Cell International Inc reported an EPS of €0.061 in its last earnings report, beating expectations of €0. Following the earnings report the stock price went up 4.348%.
Which hedge fund is a major shareholder of Cryo-Cell International Inc?
Currently, no hedge funds are holding shares in DE:ZCY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cryo-Cell International Inc
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Technical Analysis
Concord Medical Services
―
Strata Critical Medical
―
NewGenIvf Group
―
Basel Medical Group Ltd
―
20/20 Biolabs, Inc.
―